Acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase. 2006

Corinne Nguyen, and Gian Filippo Ruda, and Alessandro Schipani, and Ganasan Kasinathan, and Isabel Leal, and Alexander Musso-Buendia, and Marcel Kaiser, and Reto Brun, and Luis M Ruiz-Pérez, and Britt-Louise Sahlberg, and Nils Gunnar Johansson, and Dolores Gonzalez-Pacanowska, and Ian H Gilbert
Welsh School of Pharmacy, Cardiff University, Redwood Building, King Edward VII Avenue, Cardiff, CF10 3XF, UK.

We report the discovery of novel uracil-based acyclic compounds as inhibitors of deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase), an enzyme involved in nucleotide metabolism that has been identified as a promising target for the development of antimalarial drugs. Compounds were assayed against both P.falciparum dUTPase and intact parasites. A good correlation was observed between enzyme inhibition and cellular assays. Acyclic uracil derivatives were identified that showed greater or similar potency and in general increased selectivity compared to previously reported inhibitors. The most active compound reported here against the P. falciparum enzyme had a K(i) of 0.2 microM. Molecular modeling studies provided a good rationale for the observed activities. Preliminary ADME studies indicated that some of the lead compounds are drug-like molecules. These compounds are useful tools for further investigating P. falciparum dUTPase for the development of much-needed novel antimalarial drugs.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011755 Pyrophosphatases A group of enzymes within the class EC 3.6.1.- that catalyze the hydrolysis of diphosphate bonds, chiefly in nucleoside di- and triphosphates. They may liberate either a mono- or diphosphate. EC 3.6.1.-. Pyrophosphatase
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Corinne Nguyen, and Gian Filippo Ruda, and Alessandro Schipani, and Ganasan Kasinathan, and Isabel Leal, and Alexander Musso-Buendia, and Marcel Kaiser, and Reto Brun, and Luis M Ruiz-Pérez, and Britt-Louise Sahlberg, and Nils Gunnar Johansson, and Dolores Gonzalez-Pacanowska, and Ian H Gilbert
April 2011, Bioorganic & medicinal chemistry,
Corinne Nguyen, and Gian Filippo Ruda, and Alessandro Schipani, and Ganasan Kasinathan, and Isabel Leal, and Alexander Musso-Buendia, and Marcel Kaiser, and Reto Brun, and Luis M Ruiz-Pérez, and Britt-Louise Sahlberg, and Nils Gunnar Johansson, and Dolores Gonzalez-Pacanowska, and Ian H Gilbert
September 2013, Bioorganic & medicinal chemistry,
Corinne Nguyen, and Gian Filippo Ruda, and Alessandro Schipani, and Ganasan Kasinathan, and Isabel Leal, and Alexander Musso-Buendia, and Marcel Kaiser, and Reto Brun, and Luis M Ruiz-Pérez, and Britt-Louise Sahlberg, and Nils Gunnar Johansson, and Dolores Gonzalez-Pacanowska, and Ian H Gilbert
October 2011, ChemMedChem,
Corinne Nguyen, and Gian Filippo Ruda, and Alessandro Schipani, and Ganasan Kasinathan, and Isabel Leal, and Alexander Musso-Buendia, and Marcel Kaiser, and Reto Brun, and Luis M Ruiz-Pérez, and Britt-Louise Sahlberg, and Nils Gunnar Johansson, and Dolores Gonzalez-Pacanowska, and Ian H Gilbert
January 1998, Advances in experimental medicine and biology,
Corinne Nguyen, and Gian Filippo Ruda, and Alessandro Schipani, and Ganasan Kasinathan, and Isabel Leal, and Alexander Musso-Buendia, and Marcel Kaiser, and Reto Brun, and Luis M Ruiz-Pérez, and Britt-Louise Sahlberg, and Nils Gunnar Johansson, and Dolores Gonzalez-Pacanowska, and Ian H Gilbert
August 2023, ChemMedChem,
Corinne Nguyen, and Gian Filippo Ruda, and Alessandro Schipani, and Ganasan Kasinathan, and Isabel Leal, and Alexander Musso-Buendia, and Marcel Kaiser, and Reto Brun, and Luis M Ruiz-Pérez, and Britt-Louise Sahlberg, and Nils Gunnar Johansson, and Dolores Gonzalez-Pacanowska, and Ian H Gilbert
May 2011, Bioorganic & medicinal chemistry letters,
Corinne Nguyen, and Gian Filippo Ruda, and Alessandro Schipani, and Ganasan Kasinathan, and Isabel Leal, and Alexander Musso-Buendia, and Marcel Kaiser, and Reto Brun, and Luis M Ruiz-Pérez, and Britt-Louise Sahlberg, and Nils Gunnar Johansson, and Dolores Gonzalez-Pacanowska, and Ian H Gilbert
July 2008, ChemMedChem,
Corinne Nguyen, and Gian Filippo Ruda, and Alessandro Schipani, and Ganasan Kasinathan, and Isabel Leal, and Alexander Musso-Buendia, and Marcel Kaiser, and Reto Brun, and Luis M Ruiz-Pérez, and Britt-Louise Sahlberg, and Nils Gunnar Johansson, and Dolores Gonzalez-Pacanowska, and Ian H Gilbert
September 2002, Journal of medicinal chemistry,
Corinne Nguyen, and Gian Filippo Ruda, and Alessandro Schipani, and Ganasan Kasinathan, and Isabel Leal, and Alexander Musso-Buendia, and Marcel Kaiser, and Reto Brun, and Luis M Ruiz-Pérez, and Britt-Louise Sahlberg, and Nils Gunnar Johansson, and Dolores Gonzalez-Pacanowska, and Ian H Gilbert
October 2015, ChemMedChem,
Corinne Nguyen, and Gian Filippo Ruda, and Alessandro Schipani, and Ganasan Kasinathan, and Isabel Leal, and Alexander Musso-Buendia, and Marcel Kaiser, and Reto Brun, and Luis M Ruiz-Pérez, and Britt-Louise Sahlberg, and Nils Gunnar Johansson, and Dolores Gonzalez-Pacanowska, and Ian H Gilbert
September 2017, Journal of medicinal chemistry,
Copied contents to your clipboard!